Warburg Pincus Selling JHP to TPG Portfolio Company
January 22, 2014
TPG-backed Par Pharmaceutical Companies has agreed to acquire JHP Pharmaceuticals from Warburg Pincus. A specialty pharmaceutical developer and manufacturer, JHP makes generic sterile injectable products and provides contract manufacturing services. It was bought by Warburg Pincus from Morgan Stanley in December 2012 for $195 million, a few months after TPG took Par private for about $1.9 billion.